These results suggest that CRC-EVs enhance the efferocytotic ability of peritoneal macrophages in vivo and that the pro-efferocytosis effect is due to the presence of MFGE8 in CRC-EVs. This evidence concerns the gene MFGE8 and colorectal carcinoma.